Free Trial

Bicycle Therapeutics (BCYC) Earnings Date, Estimates & Call Transcripts

Bicycle Therapeutics logo
$5.15 +0.25 (+5.10%)
Closing price 04:00 PM Eastern
Extended Trading
$5.05 -0.10 (-1.88%)
As of 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bicycle Therapeutics Earnings Summary

Bicycle Therapeutics announced Q1 2026 earnings on April 30, 2026, reporting an EPS of -$0.87, which missed analysts' consensus estimates of -$0.62 by $0.25. Quarterly revenue was reported to be $0.89 million, below analyst estimates of $7.50 million. With a trailing EPS of -$3.15, Bicycle Therapeutics' earnings are expected to decrease next year, from ($1.99) to ($2.07) per share.

Latest Q1
Earnings Date
Apr. 30Estimated
Consensus EPS
(Apr. 30)
-$0.62
Actual EPS
(Apr. 30)
-$0.87 Missed By -$0.25
Actual Revenue
(Apr. 30)
$0.89M

Q1 2026 Earnings Resources

Get Bicycle Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bicycle Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

BCYC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCYC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bicycle Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$1.06-$1.06-$1.06
Q2 20261-$1.08-$1.08-$1.08
Q3 20261-$1.10-$1.10-$1.10
Q4 20261-$1.14-$1.14-$1.14

Bicycle Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026-$0.6209-$0.87 -$0.2491-$0.87$7.50M$0.89M
3/18/2026Q4 2025-$1.00-$0.29+$0.71-$0.29$7.08M$47.96M
10/30/2025Q3 2025-$1.09-$0.85+$0.24-$0.85$8.25M$11.73M
8/8/2025Q2 2025-$0.95-$1.14 -$0.19-$1.14$9.43M$2.90M
5/1/2025Q1 2025-$0.86-$0.88 -$0.02-$0.88$8.67M$9.98M
2/25/2025Q4 2024-$0.85-$0.75+$0.10-$0.75$5.47M$3.70M
10/31/2024Q3 2024-$0.78-$0.74+$0.04-$0.74$6.82M$2.68M
8/6/2024Q2 2024-$1.10-$0.77+$0.33-$0.77$6.13M$9.36M

Data powered by Fiscal.ai.

Bicycle Therapeutics Earnings - Frequently Asked Questions

Bicycle Therapeutics (NASDAQ:BCYC) last announced its quarterly earning data on Thursday, April 30, 2026. Learn more on BCYC's earnings history.

In the previous quarter, Bicycle Therapeutics (NASDAQ:BCYC) missed the analysts' consensus estimate of ($0.62) by $0.25 with a reported earnings per share (EPS) of ($0.87). Learn more on analysts' earnings estimate vs. BCYC's actual earnings.

Bicycle Therapeutics (NASDAQ:BCYC) has a recorded annual revenue of $72.86 million.

Bicycle Therapeutics (NASDAQ:BCYC) has a recorded net income of -$218.96 million. BCYC has generated -$3.15 earnings per share over the last four quarters.

Bicycle Therapeutics' earnings are expected to decrease from ($1.99) per share to ($2.07) per share in the next year.


This page (NASDAQ:BCYC) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners